Eton Pharmaceuticals Inc

ETON03 Dec 2024
Healthcare
$13.66
-0.08 (-7.91%)
Lowest Today
$12.03
Highest Today
$13.98
Today’s Open
$13.66
Prev. Close
$13.53
52 Week High
$13.98
52 Week Low
$3.03
To Invest in Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc

Healthcare
ETON03 Dec 2024
-0.08 (-7.91%)
1M
3M
6M
1Y
5Y
Low
$12.03
Day’s Range
High
$13.98
12.03
52 Week Low
$3.03
52-Week Range
52 Week High
$13.98
3.03
1 Day
-
1 Week
+0.4%
1 month return
+49.58%
3 month return
+168.6%
6 month return
+246.94%
1 Year return
+245.98%
3 Years return
+240.32%
5 Years return
+103.42%
10 Years return
-
Institutional Holdings
Opaleye Management Inc
10.76
Vanguard Group Inc
3.98
Nantahala Capital Management, LLC
3.87
Vanguard Total Stock Mkt Idx Inv
2.64
Westside Investment Management, Inc.
2.27
Acuitas Investments, LLC
2.24
EcoR1 Capital, LLC
2.19

Market Status

Fundamentals
Market Cap
236.92 mln
PB Ratio
21.87
PE Ratio
0
Enterprise Value
333.55 mln
Total Assets
31.74 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Organisation
Eton Pharmaceuticals Inc
Employees
30
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Sean E. Brynjelsen
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities